Fondazione IRCCS Istituto Nazionale dei Tumori-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2022

  1. Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma

    Liver International, Vol. 42, Núm. 12, pp. 2855-2870

2019

  1. Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma

    American Journal of Pathology, Vol. 189, Núm. 10, pp. 2090-2101